Multiple Hims & Hers Executives Report Share Disposals as Chief Accounting Officer Departs

The filings and the CAO's exit could affect investor confidence as the company copes with recent losses, a shift to branded drugs, and pending legal challenges.

Overview

Several senior Hims & Hers executives filed SEC Form 4 disclosures showing share sales, including CFO Oluyemi Okupe reporting disposal of 101,000 shares and CMO Patrick Harrison Carroll selling 10,201 shares.
Chief accounting officer Irene Becklund reported a non‑discretionary sale of 6,490 shares and is reported to be leaving the company, creating a change in the finance leadership team.
Chief legal officer Soleil Boughton also disclosed a non‑discretionary disposition of 21,500 shares tied to tax withholding on vested awards, not an active trading decision.
These filings come after the company’s Aug. 10 quarter in which revenue beat estimates but it recorded a net loss driven by a move toward higher‑priced branded GLP‑1 drugs, acquisition and restructuring costs, and a $47.5 million legal reserve related to an FTC and multi‑state lawsuit.
Investors are watching the insider activity and leadership turnover for signs of shifting sentiment, but Form 4 rules and non‑discretionary trades mean the transactions do not by themselves prove executives’ current views on company prospects; Hims & Hers remains a large digital‑health platform with reported $2.6 billion TTM revenue and about a $6.4 billion market value.